Search results
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
Motley Fool via Yahoo Finance· 2 hours agoHere's what's going on and why it's likely to remain relevant for investors for at least the next...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
CW39 NewsFix· 6 days agoWASHINGTON (AP) — Federal health advisers are weighing the first-of-a-kind approval of MDMA, the...
Panel rejects psychedelic drug MDMA as a PTSD treatment in setback for advocates
Los Angeles Times· 6 days agoFederal health advisers voted Tuesday against a first-of-a-kind proposal to use the mind-altering...
Boston doctor weighs on using psychedelic drugs to treat PTSD
WCVB Boston· 5 days agoCARDIO MYOPATHY AND ADVISORY GROUP FOR THE FDA HAS VOTED AGAINST USING PSYCHEDELIC DRUGS TO TREAT...
Psychedelic drug MDMA could be ‘a new avenue of treatment’ as FDA begins its first-ever review
Fast Company Magazine· 6 days agoA panel of advisers to the U.S. Food and Drug Administration will meet on Tuesday to discuss a...
FDA panel rejects the use of psychedelic drug MDMA to treat patients with PTSD
AOL· 5 days agoIt marked the first time the FDA has considered an illicit psychedelic drug for medical use, but...
Psychedelic Drug Stocks Plummet On FDA Advisers' Doubts About Ecstasy Candidate
The Wall Street Journal· 5 days agoStocks for companies developing psychedelic treatments fell Wednesday after advisers to the Food and...